Creating bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases
Notable Achievements
- Raised over US$260 million in capital
- Entered partnership with healthcare leader Novo Nordisk to develop therapies for diabetes and obesity
- Named to Fast Company's list of Next Big Things in Tech & Biotech Company of the Year by BIOTECanada
Currently Operating in One Region
Press Mentions
July 14, 2025
Aspect Biosystems Presents New Preclinical Data on Adrenal Bioprinted Tissue Therapeutics at ENDO 2025
Aspect Biosystems presented promising preclinical data on its bioprinted adrenal tissue therapeutics at ENDO 2025. This breakthrough demonstrates the company's innovative approach to regenerative...
Read more »
January 13, 2025
Game-Changing $115M for Aspect Biosystems’ Bioprinted Tech - 3DPrint.com
Aspect Biosystems has successfully raised $115 million in a Series B financing round, enhancing its capabilities in bioprinted tissue therapeutics. This funding positions the company to advance its...
Read on sp3d »
January 8, 2025
Vancouver’s Aspect Biosystems raises $115-million to develop 3-D printed human tissue technology
Aspect Biosystems has successfully raised $115 million in Series B financing to advance its innovative 3D bioprinting technology for tissue therapeutics. This funding will enhance their...
Read on The Globe and Mail »
September 20, 2024
11 Canadian tech companies to watch in 2020 - ImHecate
Aspect Biosystems is celebrated for its groundbreaking advancements in bioprinting technology, revolutionizing tissue engineering. Recognized as a top Canadian tech company to watch in 2020, it...
Read on ImHecate »
July 11, 2024
Aspect Biosystems gets over $70 million in government investment to continue innovative work - BC Business
Aspect Biosystems secures a $200 million partnership with the governments of Canada and British Columbia for bioprinted tissue therapeutics. The investment aims to drive biotech innovation in...
Read on BC Business »
July 10, 2024
$200 million federal, BC & tech partnership partnership in bioprinted tissue therapeutics - Island Social Trends
Canada and British Columbia partner in a $200 million deal with Aspect Biosystems to advance bioprinted tissue therapeutics. The collaboration aims to revolutionize healthcare by developing...
Read on Island Social Trends »Work at Aspect Biosystems
Posted July 10, 2025
Head, Manufacturing and Facility Operations
Vancouver, BC, Canada
View Listing »Posted May 15, 2025
Senior Scientist, Cryopreservation Process Development
Vancouver, BC, Canada
View Listing »Posted May 15, 2025
Scientist, Process Development (Bioprinting CMC)
Vancouver, BC, Canada
View Listing »More Ventures in Health
Get the Unreasonable Newsletter
Get monthly updates on Aspect Biosystems and all of the other ventures working to solve the world's toughest problems.